Print Page

Products found to contain undeclared medicines

The United States: Maxiloss Weight Advanced Softgels: Recall - Undeclared Drug Ingredient Sibutramine
The Food and Drug Administration (FDA) announced that Olaax Corp is conducting a voluntary nationwide recall of the company's dietary supplement sold under the brand name Maxiloss Weight Advanced Softgels to the user level, because FDA testing found the Maxiloss Weight Advanced product to contain Sibutramine. Sibutramine was a previously approved controlled substance for the treatment of obesity that was removed from the US market in October 2010 for safety reasons, making this product an unapproved new drug. The active drug ingredient is not listed on the label for these products.

Maxiloss Weight Advanced Softgels is marketed as a Natural Herb for Weight Loss. The product is packaged in a green or blue box containing 3 X 12 blister packs per box and bears "Batch Number: 001". The product was sold to distributors nationwide, and known-to-be counterfeit versions are sold on various online sites. This product was distributed nationwide in US from January 2011 to November 2012. The recall includes ALL authentic lot numbers and known to be counterfeit lot numbers of authentic lots. Any packaging types that are different from listed are counterfeit. Any lot numbers not listed are counterfeit and are also part of the recall. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking this drug product.

Please refer to the following website in FDA for details:

In Hong Kong, the above product is not a registered pharmaceutical product. Related news has been released by FDA and was posted on the website of Drug Office on 9 January 2013.

Ends/ Tuesday, February 26, 2013
Issued at HKT 12:00

Related Information:
The United States: Public Notificaiton: “MAXILOSS Weight Advanced” contains hidd... Posted 2013-01-09